Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene

Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is an exercise and emotional stress-induced life-threatening inherited heart rhythm disorder, characterized by an abnormal cellular calcium homeostasis. Most reported cases have been linked to mutations in the gene encoding the type 2 ryan...

Full description

Bibliographic Details
Main Authors:	Bastien Cimarosti, Robin Canac, Stephan De Waard, Aurore Girardeau, Anne Gaignerie, Aude Derevier, Virginie Forest, Michel Ronjat, Hervé Le Marec, Jean-Baptiste Gourraud, Patricia Lemarchand, Michel De Waard, Guillaume Lamirault, Nathalie Gaborit
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S187350612200037X

Similar Items

Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
by: Angela F. Dulhunty
Published: (2022-02-01)

Deciphering Transcriptional Networks during Human Cardiac Development
by: Robin Canac, et al.
Published: (2022-12-01)

Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT)
by: Michele Violano, et al.
Published: (2022-08-01)

Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry.
by: Thomas M Roston, et al.
Published: (2018-01-01)

Generation of human induced pluripotent stem cell lines from four unrelated healthy control donors carrying European genetic background
by: Aurore Girardeau, et al.
Published: (2022-03-01)

Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells
by: Stephan De Waard, et al.
Published: (2020-09-01)

Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients.
by: Seiko Ohno, et al.
Published: (2015-01-01)

Impaired ligand regulation of native RyR2 channels in the catecholaminergic polymorphic ventricular tachycardia mutation, RyR2-V2475F(+/−)
by: Wilson, A, et al.
Published: (2019)

Correction: Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients.
by: Seiko Ohno, et al.
Published: (2021-01-01)

The V2475F CPVT1 mutation yields distinct RyR2 channel populations that differ in their responses to cytosolic Ca2+ and Mg2+
by: Wilson, AD, et al.
Published: (2021)

Cell Penetration Properties of a Highly Efficient Mini Maurocalcine Peptide
by: Michel De Waard, et al.
Published: (2013-03-01)

The RyR2-R2474S Mutation Sensitizes Cardiomyocytes and Hearts to Catecholaminergic Stress-Induced Oxidation of the Mitochondrial Glutathione Pool
by: Jörg W. Wegener, et al.
Published: (2021-12-01)

Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 gene
by: Viviana Meraviglia, et al.
Published: (2020-05-01)

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations
by: Xiaohui Kong, et al.
Published: (2023-06-01)

Catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2 mutation: recreational cycling as a trigger of lethal arrhythmias
by: Antonio Cortez, et al.
Published: (2019-11-01)

Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A
by: Yanmin Zhang, et al.
Published: (2019-08-01)

P456: Novel variant of unknown significance in RYR2 in a patient with suspected catecholaminergic polymorphic ventricular tachycardia: A case to reclassify
by: Dorota Gruber, et al.
Published: (2024-01-01)

Diagnosis of catecholaminergic polymorphic ventricular tachycardia during late adulthood due to a rare genetic variant in RYR2: a case report
by: Laura García-Cano, et al.
Published: (2021-08-01)

Generation of iPSC lines from CPVT patient carrying heterozygous mutation p.A2254V in the ryanodine receptor 2 gene
by: Wener Li, et al.
Published: (2021-05-01)

Electrical Efficiency Increase in CPVT Collectors by Spectral Splitting
by: Alois Resch, et al.
Published: (2021-12-01)

Prenatal diagnosis identifies compound heterozygous variants in RYR1 that causes ultrasound abnormalities in a fetus
by: Qiuling Zhao, et al.
Published: (2022-09-01)

CPVT and Complete Atrio-Ventricular Block: The Flipside of the Same Coin
by: Mattia Petrungaro, et al.
Published: (2023-02-01)

The Purkinje–myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT
by: Daniel J. Blackwell, et al.
Published: (2022-02-01)

P700: Heterozygous deletion of valine at position 2321 of RYR2 in two siblings with sudden cardiac death
by: Eric Kao, et al.
Published: (2024-01-01)

Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report
by: L. K. Seidlmayer, et al.
Published: (2018-10-01)

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
by: Amandine Caillaud, et al.
Published: (2022-12-01)

Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four‐generation Canadian family
by: Matthew Tung, et al.
Published: (2020-04-01)

A Review on Heat Extraction Devices for CPVT Systems with Active Liquid Cooling
by: Karolina Papis-Frączek, et al.
Published: (2022-08-01)

CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature
by: Giannis G. Baltogiannis, et al.
Published: (2019-07-01)

Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases
by: Steven Ascoët, et al.
Published: (2020-05-01)

Catecholaminergic Polymorphic Ventricular Tachycardia
by: Mohamed Abbas, et al.
Published: (2022-10-01)

Catecholaminergic modulation of meta-learning
by: Jennifer L Cook, et al.
Published: (2019-12-01)

Chemical Synthesis of a Functional Fluorescent-Tagged α-Bungarotoxin
by: Oliver Brun, et al.
Published: (2022-01-01)

Aptamer Efficacies for In Vitro and In Vivo Modulation of αC-Conotoxin PrXA Pharmacology
by: Germain Sotoing Taiwe, et al.
Published: (2019-01-01)

Energy exergy and economic evaluation of a CCHP configuration powered by CPVT collectors dynamically
by: Seyed Mohammadreza Esmaeili, et al.
Published: (2023-12-01)

On the Incompleteness of Birkhoff’s Theorem: A New Approach to the Central Symmetric Gravitational Field in Vacuum Space
by: Michel Canac
Published: (2023-01-01)

Generation of a patient-specific induced pluripotent stem cell line carrying the DES p.R406W mutation, an isogenic control and a DES p.R406W knock-in line
by: Michelle Geryk, et al.
Published: (2024-06-01)

Modification of cardiac RYR2 gating by a peptide from the central domain of the RYR2
by: Faltinová Andrea, et al.
Published: (2013-12-01)

Study of catecholaminergic cells in murine heart
by: Sun, T
Published: (2021)

Catecholaminergic polymorphic ventricular tachycardia in 2012
by: Christian van der Werf, et al.
Published: (2011-12-01)